Skip to main content
Clinical Trials/NL-OMON44678
NL-OMON44678
Completed
Not Applicable

Reducing Micro Vascular dysfunction In revascularized STEMI patients by off-target properties of ticagrelor - REDUCE-MVI

Vrije Universiteit Medisch Centrum0 sites110 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Vrije Universiteit Medisch Centrum
Enrollment
110
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Provision of informed consent
  • 2\. Patients presenting with STEMI \<12 hours
  • 3\. Successful PCI of the infarct\-related vessel with a modern DES
  • 4\. Intermediate stenosis in non\-infarct\-related vessel (50\-90%)

Exclusion Criteria

  • 1\. history of myocardial infarction
  • 2\. Participation in another clinical study with an investigational product during the preceding 30 days
  • 3\. history of cerebrovascular accident (CVA) or 'transient ischaemic attack' (TIA)
  • 4\. History of intracranial haemorrhage
  • 5\. indication or use of oral anticoagulant therapy (i.e. acenocoumarol)
  • 6\. severe liver dysfunction (Child\-Pughscore 10\-15\)
  • 7\. congestive heart failure
  • 8\. cardiogenic shock
  • 9\. left ventricular ejection fraction \< 35%
  • 10\. bleeding diathesis

Outcomes

Primary Outcomes

Not specified

Similar Trials